Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120262) titled 'Efficacy Evaluation of Berberine in Improving Cardiovascular Disease Risk in Patients with Polycystic Ovary Syndrome' on March 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Obstetris & Gynecology Hospital of Fudan University
Condition:
Polycystic ovary syndrome (PCOS)
Intervention:
PCOS berberine treatment group:berberine treatment
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-15
Target Sample Size: PCOS berberine treatment group:188;PCOS control group:188;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org....